X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs AJANTA PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA AJANTA PHARMA FULFORD INDIA/
AJANTA PHARMA
 
P/E (TTM) x 398.8 21.7 1,836.7% View Chart
P/BV x 6.2 9.4 66.2% View Chart
Dividend Yield % 0.1 0.6 13.2%  

Financials

 FULFORD INDIA   AJANTA PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
AJANTA PHARMA
Mar-16
FULFORD INDIA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs9421,720 54.8%   
Low Rs4501,103 40.8%   
Sales per share (Unadj.) Rs691.4194.6 355.3%  
Earnings per share (Unadj.) Rs11.545.2 25.3%  
Cash flow per share (Unadj.) Rs15.450.3 30.5%  
Dividends per share (Unadj.) Rs2.008.00 25.0%  
Dividend yield (eoy) %0.30.6 50.7%  
Book value per share (Unadj.) Rs380.0132.0 287.8%  
Shares outstanding (eoy) m3.9088.77 4.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.07.3 13.9%   
Avg P/E ratio x60.731.2 194.5%  
P/CF ratio (eoy) x45.328.1 161.5%  
Price / Book Value ratio x1.810.7 17.1%  
Dividend payout %17.417.7 98.6%   
Avg Mkt Cap Rs m2,714125,299 2.2%   
No. of employees `0000.4NA-   
Total wages/salary Rs m5052,570 19.7%   
Avg. sales/employee Rs Th6,073.0NM-  
Avg. wages/employee Rs Th1,137.4NM-  
Avg. net profit/employee Rs Th100.7NM-  
INCOME DATA
Net Sales Rs m2,69617,275 15.6%  
Other income Rs m125166 75.4%   
Total revenues Rs m2,82217,442 16.2%   
Gross profit Rs m-465,807 -0.8%  
Depreciation Rs m15451 3.4%   
Interest Rs m1049 19.4%   
Profit before tax Rs m545,474 1.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m101,460 0.7%   
Profit after tax Rs m454,014 1.1%  
Gross profit margin %-1.733.6 -5.1%  
Effective tax rate %17.726.7 66.3%   
Net profit margin %1.723.2 7.1%  
BALANCE SHEET DATA
Current assets Rs m1,7387,639 22.8%   
Current liabilities Rs m5452,715 20.1%   
Net working cap to sales %44.328.5 155.3%  
Current ratio x3.22.8 113.4%  
Inventory Days Days4843 112.1%  
Debtors Days Days479 5.5%  
Net fixed assets Rs m126,914 0.2%   
Share capital Rs m39177 22.0%   
"Free" reserves Rs m1,44311,442 12.6%   
Net worth Rs m1,48211,721 12.6%   
Long term debt Rs m0149 0.0%   
Total assets Rs m2,07714,814 14.0%  
Interest coverage x6.7112.9 5.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.31.2 111.3%   
Return on assets %2.627.4 9.5%  
Return on equity %3.034.2 8.8%  
Return on capital %4.346.5 9.3%  
Exports to sales %055.1 0.0%   
Imports to sales %24.56.0 407.1%   
Exports (fob) Rs mNA9,527 0.0%   
Imports (cif) Rs m6591,038 63.5%   
Fx inflow Rs m1710,422 0.2%   
Fx outflow Rs m6731,678 40.1%   
Net fx Rs m-6568,744 -7.5%   
CASH FLOW
From Operations Rs m903,264 2.8%  
From Investments Rs m105-2,093 -5.0%  
From Financial Activity Rs m-14-1,186 1.2%  
Net Cashflow Rs m181-15 -1,219.6%  

Share Holding

Indian Promoters % 0.0 73.8 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 1.6 245.2%  
FIIs % 0.1 7.6 1.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 17.0 124.7%  
Shareholders   4,783 20,968 22.8%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare FULFORD INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Pharma Drug Approvals, Global Updates, Oil Prices, and Top Stocks in Action Today(Pre-Open)

Indian share markets snapped their losing streak seen during last week and closed their Wednesday session on a positive note.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS